CrushSCI.com
202.7Average days
205Median days
61Fastest days
393Longest days
4542025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

82 days

AI-based prediction of actionable genomic alterations from H&E-stained slides

Authors
Woochan Hwang; Fernando Lopez-Rios; Kashif Firozvi; Vivek Subbiah; Siraj M. AliShow moreShow less
Affiliations
1. Department of Medicine, Mount Auburn Hospital, Cambridge, USA; 2. Lunit Inc, Seoul, Republic of Korea; 3. Department of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre (i + 12), CIBERONC, Madrid, Spain; 4. Maryland Oncology Hematology, Silver Spring, USA; 5. Division of Oncology, Stanford University School of Medicine, Palo Alto, USAShow moreShow less
Source PDF DOI Publisher page
217 days

Stromal VEGF-C expression predicts nodal metastasis: implications for axillary surgery de-escalation in breast cancer

Authors
Pauline Jeannot; Emelie Edvardsson; Oscar Hernquist; Cornelia Brandt; Linnea Fischhaber; Anna-Maria Larsson; Beatrice Öhlund; Kristian Pietras; Pär-Ola Bendahl; Charlotte Rolny; Lisa RydenShow moreShow less
Affiliations
1. Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden; 2. Lund University Cancer Centre, Lund University, Lund, Sweden; 3. Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden; 4. SciLifeLab, Department of Laboratory Medicine, Lund University, Lund, Sweden; 5. Department of Gastroenterology and Surgery, Skåne University Hospital, Malmö, Sweden; 6. CIRCE: Centre for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, SwedenShow moreShow less
Source PDF DOI Publisher page
61 days

Decoding small cell lung cancer vulnerabilities: the AI pathway to next-gen therapeutics

Authors
Mu Li; Lei Zhang; Zhenglun Yu; Jun Li; Shuo Wang; Simeng ZhangShow moreShow less
Affiliations
1. Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China; 2. Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, China; 3. Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China; 4. Department of Ophthalmology, The First Hospital of China Medical University, Shenyang, China; 5. Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, ChinaShow moreShow less
Source PDF DOI Publisher page
111 days

Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears

Authors
Jan-Niklas Eckardt; Chethan Babu V. Reddy; Andrew Srisuwananukorn; Christian Pohlkamp; Maryam Schübel; Ishan Srivastava; Miriam Stoerk; Sebastian Riechert; Tim Schmittmann; Martin M. K. Schneider; Klaus H. Metzeler; Karsten Spiekermann; Markus Badstübner; Susann Winter; Katja Sockel; Frank Kroschinsky; Christoph Röllig; Martin Bornhäuser; Tobias Herold; Torsten Haferlach; Ann-Kathrin Eisfeld; Jan Moritz MiddekeShow moreShow less
Affiliations
1. Department of Internal Medicine I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 2. Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany; 3. Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 4. Cancilico GmbH, Dresden, Germany; 5. Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, USA; 6. MLL Munich Leukemia Laboratory, Munich, Germany; 7. Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; 8. Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany; 9. German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 10. National Center for Tumor Diseases (NCT), NCT//UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 11. Department of Hematology, Oncology, and Stem-Cell Transplantation, Munich Hospital Bogenhausen, Munich Municipal Hospital Group, Munich, GermanyShow moreShow less
Source PDF DOI Publisher page
393 days

The promise and limits of patient-reported outcomes in molecular tumor board-guided care: toward a framework for patient-centered precision oncology

Authors
L. Gräßel; S. Yacob; C. Strantz; E. Prochaska; T. Debertshäuser; AA. Rogge; S. Bäcker; F. Prasser; P. Unberath; J. Wehrle; S. Jäger; M. Boerries; AL Illert; U. Lührig; M. WolfienShow moreShow less
Affiliations
1. Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany; 2. Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 3. Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 4. Institute for Medical Informatics and Biometry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 5. Charité - Universitätsmedizin Berlin, Berlin Institute of Health @ Charité, Berlin, Germany; 6. Center for Patient-Centered Outcomes Research, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 7. Department of Psychosomatic Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 8. Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 9. SRH Fürth University of Applied Sciences, Fürth, Germany; 10. Data Integration Center, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Freiburg, Germany; 11. Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 12. Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; 13. Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI Dresden/Leipzig), Dresden, Saxony, GermanyShow moreShow less
Source PDF DOI Publisher page
236 days

An individual sample predictive model to classify patients with metastatic renal cell carcinoma

Authors
Anupama Reddy; W. Jared Brewer; Scott M. Haake; Brian RiniShow moreShow less
Affiliations
1. Vindhya Data Science, Morrisville, USA; 2. Vanderbilt University Medical Center, Nashville, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does npj Precision Oncology take to review a manuscript?

As of 2026-11-18, CrushSCI has 21 complete review records for npj Precision Oncology. The fastest paper went from submission to acceptance in 61 days (Decoding small cell lung cancer vulnerabilities: the AI pathway to next-gen therapeutics, received 2026-07-04, accepted 2026-09-03); the slowest took 393 days. The average is 202.7 days and the median is 205 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.